Our Pipeline

Last updated, April 2021.

Molecule / Project
Indication
Expected Launch
Preclinical Phase Phase I Phase II Phase III Under Registration Geography
Tirbanibulin Actinic Keratosis 2021
90 Under registration
EU EU
UK UK
MC2-01 Psoriasis 2021
90 Under registration
EU EU
UK UK
Lebrikizumab Atopic dermatitis 2023
56 Fase2
EU EU
UK UK
Sarecycline Acne 2023
48 Fase2
China China

Actinic Keratosis Tirbanibulin 2021 Under registration eu uk

Psoriasis MC2-01 2021 Under registration eu uk

Atopic dermatitis Lebrikizumab 2023 Fase2 eu uk

Acne Sarecycline 2023 Fase2 china

Programs in Research & Preclinical